Who backs Alchemab Therapeutics?
11 investors| Investor | Type |
|---|---|
| Innovate UK | Other |
| RA Capital Management | Asset manager |
| DCVC | Venture capital |
| SV Health Investors | Venture capital |
| Camford Capital | Venture capital |
| DHVC | Venture capital |
| DCVC Bio | Venture capital |
| Lightstone Ventures | Venture capital |
| BioIndustry Association | — |
| Eli Lilly | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Alchemab Therapeutics investors
11 investors are on record for Alchemab Therapeutics, including Innovate UK, RA Capital Management, DCVC and SV Health Investors. By type, the record holds 6 venture capital firms and 1 asset manager. The Series A in Sep 2025 drew 6 investors.
Free account
More of Alchemab Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Alchemab Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Alchemab Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View